Vimarsana
Biggest News Aggregation in the World

Max Herrmann News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Max Herrmann. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Max Herrmann Today - Breaking & Trending Today

Valneva SE (NASDAQ:VALN) Q2 2023 Earnings Call Transcript - Vimarsana News

Valneva SE (NASDAQ:VALN) Q2 2023 Earnings Call Transcript

Published: September 27, 2023

Valneva SE (NASDAQ:VALN) Q2 2023 Earnings Call Transcript September 21, 2023 Valneva SE misses on earnings expectations. Reported EPS is $0.26 EPS, expectations were $0.36. Operator: Good day, and thank you for standing by. Welcome to the Valneva Half Year 2023 Financial Results Call and Webcast. [Operator Instructions] Please note that today’s conference is being […]

Source: yahoo.com
Related Topics:
United StatesKingdom Of BahrainThomas LingelbachSamir DevaniSuzanne Van VoorthuizenDamien ChoplainMaury RaycroftSimon ScholesMax HerrmannPressmaster ShutterstockPeter BuhlerInstituto ButantanBevan WangFrench Market AuthorityExchange CommissionHealth CanadaFast Track DesignationTarget Product ProfileLow CostJobs That PayVan VoorthuizenVaccine DevelopmentChikungunya VirusPeter BuhlerPerator Instructions
Investment in Britain has reached 'crisis' point, says Citi boss - Vimarsana News

Investment in Britain has reached 'crisis' point, says Citi boss

Published: September 8, 2023

David Livingstone raises alarm over increasing reliance on foreign investors

Source: telegraph.co.uk
Related Topics:
City OfUnited KingdomNew YorkUnited StatesWilliam WrightDavid LivingstoneMarshall WaceJohn DawsonPaul MarshallMax HerrmannArm HoldingsMiddle EastNew FinancialUnited Kingdom FoundedDechra PharmaceuticalsStifel HealthcareUnited Kingdom Capital MarketsNew SenseLondon Stock Exchange GroupUk Economy
Private equity swoops on UK pharma firm in £703.1m deal: Ergomed founder lands £120m windfall - Vimarsana News

Private equity swoops on UK pharma firm in £703.1m deal: Ergomed founder lands £120m windfall

Published: September 5, 2023

Ergomed founder and executive chairman Miroslav Reljanovic's (pictured) stake in the biotech firm is currently valued at £123m.

Source: dailymail.co.uk
Related Topics:
United KingdomCity OfJohn DawsonSean ConroyMax HerrmannDanni HewsonMiroslav ReljanovicUltra ElectronicsLondon Stock ExchangeStifel HealthcareUnited Kingdom BasedFor LondonShore CapitalLondon Stock
Private equity swoops on UK pharma firm in £703.1m deal: Ergomed founder lands £120m windfall - Vimarsana News

Private equity swoops on UK pharma firm in £703.1m deal: Ergomed founder lands £120m windfall

Published: September 4, 2023

Ergomed founder and executive chairman Miroslav Reljanovic's (pictured) stake in the biotech firm is currently valued at £123m.

Source: thisismoney.co.uk
Related Topics:
City OfUnited KingdomMax HerrmannJohn DawsonDanni HewsonSean ConroyMiroslav ReljanovicUltra ElectronicsLondon Stock ExchangeStifel HealthcareUnited Kingdom BasedFor LondonShore CapitalLondon Stock
FDA delays decision on Valneva's chikungunya vaccine - Vimarsana News

FDA delays decision on Valneva's chikungunya vaccine

Published: August 14, 2023

BioPharma

Source: biopharmadive.com
Related Topics:
Max HerrmannDrug AdministrationBavarian Nordic